NCT03951207View on ClinicalTrials.gov

Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia

PHASE4CompletedINTERVENTIONAL
Enrollment

259

Participants

Timeline

Start Date

May 30, 2019

Primary Completion Date

September 29, 2021

Study Completion Date

September 29, 2021

Conditions
DyslipidemiasHypertension
Interventions
DRUG

Rosuampin 10/5mg

Rosuvastatin 10mg/Amlodipine 5mg qd for 8 weeks

DRUG

Rosuampin 20/5mg

Rosuampin 20/5mg qd for 8 weeks

DRUG

Amlodipine/Atorvastatin 5/20mg

Amlodipine/Atorvastatin 5/20mg qd for 8 weeks

Trial Locations (1)

Unknown

Daegu Catholic Univ. Medical Center, Daegu

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT03951207 - Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia | Biotech Hunter | Biotech Hunter